Get the Stockscreener App
23.54
1.79%
-0.43
After Hours:
23.98
0.44
+1.87%
Veracyte Inc stock is traded at $23.54, with a volume of 1.43M.
It is down -1.79% in the last 24 hours and down -12.91% over the past month.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder). In addition, its Percepta Nasal Swab test is being run in CLIA labs in support of clinical studies.
See More
Previous Close:
$23.97
Open:
$23.64
24h Volume:
1.43M
Relative Volume:
1.07
Market Cap:
$1.84B
Revenue:
$399.58M
Net Income/Loss:
$-54.04M
P/E Ratio:
-31.39
EPS:
-0.75
Net Cash Flow:
$40.13M
1W Performance:
-0.21%
1M Performance:
-12.91%
6M Performance:
-48.24%
1Y Performance:
-1.92%
1-Day Range:
$23.30
$24.23
1-Week Range:
$23.30
$26.11
52-Week Range:
$19.73
$47.32
Veracyte Inc Stock (VCYT) Company Profile
Name
Veracyte Inc
Sector
Industry
Phone
(650) 243-6300
Address
6000 SHORELINE COURT, SUITE 300, SOUTH SAN FRANCISCO, CA
Compare VCYT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCYT
Veracyte Inc
|
23.54 | 1.88B | 399.58M | -54.04M | 40.13M | -0.75 |
|
TMO
Thermo Fisher Scientific Inc
|
467.68 | 180.17B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
197.16 | 146.07B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
534.31 | 46.01B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
114.81 | 33.53B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
185.86 | 32.56B | 15.50B | 1.33B | 2.16B | 7.34 |
Veracyte Inc Stock (VCYT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-20-25 | Initiated | Craig Hallum | Buy |
| Dec-05-24 | Downgrade | Goldman | Buy → Neutral |
| Nov-15-24 | Initiated | Wolfe Research | Outperform |
| Oct-16-24 | Initiated | UBS | Buy |
| Oct-10-24 | Initiated | Guggenheim | Buy |
| Feb-23-24 | Reiterated | Needham | Buy |
| Jan-18-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-05-23 | Initiated | Scotiabank | Sector Outperform |
| Jan-07-22 | Initiated | Stephens | Overweight |
| Nov-18-21 | Resumed | Goldman | Buy |
| Jun-15-21 | Initiated | Raymond James | Outperform |
| Feb-18-21 | Resumed | Needham | Buy |
| Jan-28-21 | Initiated | Truist | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-09-20 | Initiated | Morgan Stanley | Underweight |
| Jul-31-19 | Initiated | Lake Street | Buy |
| Jul-02-19 | Initiated | Needham | Buy |
| Nov-29-18 | Downgrade | Janney | Buy → Neutral |
| Oct-31-18 | Upgrade | Janney | Neutral → Buy |
| Nov-07-17 | Downgrade | Janney | Buy → Neutral |
| Nov-07-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-31-17 | Resumed | BTIG Research | Buy |
| Nov-14-16 | Resumed | Leerink Partners | Outperform |
| Dec-18-15 | Initiated | Cantor Fitzgerald | Buy |
| Jun-11-15 | Reiterated | Leerink Partners | Outperform |
| Nov-26-13 | Initiated | William Blair | Outperform |
View All
Veracyte Inc Stock (VCYT) Latest News
Should I hold or sell Veracyte Inc. stock in 2025Daily Trading Forecasts From AI Tools - jammulinksnews.com
Veracyte (VCYT) Soars 7% on S&P SmallCap 600 Inclusion - MSN
What is the dividend policy of Veracyte Inc. stockValue Investing Data Feed For Beginners - jammulinksnews.com
Declining Stock and Decent Financials: Is The Market Wrong About Veracyte, Inc. (NASDAQ:VCYT)? - Yahoo.co
Why Veracyte Inc. stock attracts strong analyst attentionConsistent Gain Investment Strategies Emerge - beatles.ru
Historical volatility pattern of Veracyte Inc. visualizedHistorical Stock Summary and ROI Review - Newser
How institutional ownership impacts Veracyte Inc. stockShort-Term Swing Opportunity Summary Sheet - Newser
Veracyte's S&P SmallCap 600 Inclusion: A Catalyst for Institutional Momentum and Long-Term Growth? - AInvest
Veracyte's Index Inclusion: A Catalyst for Healthcare's Long-Term Resilience - AInvest
Is it the right time to buy Veracyte Inc. stockAchieve rapid portfolio growth with expert guidance - jammulinksnews.com
Veracyte (VCYT) Soars 7.0%: Is Further Upside Left in the Stock? - Yahoo Finance
What are the technical indicators suggesting about Veracyte Inc.Free Wealth Planning Blueprint - jammulinksnews.com
Is Veracyte Inc. a Top Dividend Stock to Watch in 2025Top Gaining Low Risk Assets - metal.it
How strong is Veracyte Inc. company’s balance sheetExceptional earning trajectories - jammulinksnews.com
What are analysts’ price targets for Veracyte Inc. in the next 12 monthsExceptional profit margins - jammulinksnews.com
How does Veracyte Inc. generate profit in a changing economyRobust investment performance - jammulinksnews.com
Will Veracyte Inc. Stock Benefit from AI and Green Energy TrendsHigh Return Conservative Stocks - metal.it
What is the risk reward ratio of investing in Veracyte Inc. stockBuild a balanced portfolio for long-term success - jammulinksnews.com
How Resilient Is Veracyte Inc. Stock During Economic DownturnsFree Stock Market Swing Trading Strategies - metal.it
What institutional investors are buying Veracyte Inc. stockInvest confidently with proven investment plans - jammulinksnews.com
What analysts say about Veracyte Inc. stockUnprecedented growth rates - PrintWeekIndia
Veracyte stock soars after S&P SmallCap 600 addition announcement By Investing.com - Investing.com Nigeria
Veracyte stock soars after S&P SmallCap 600 addition announcement - Investing.com
Veracyte Inc. Stock Analysis and ForecastDynamic profit opportunities - PrintWeekIndia
Veracyte jumps after diagnostics company to join S&P 600 Small Cap Index - TradingView
Veracyte Set to Join S&P SmallCap 600 | VCYT Stock News - GuruFocus
Veracyte's S&P SmallCap 600 Inclusion: A Catalyst for Small-Cap Healthcare Innovation - AInvest
Veracyte Set to Join S&P SmallCap 600 - 富途牛牛
Investors Don't See Light At End Of Veracyte, Inc.'s (NASDAQ:VCYT) Tunnel - 富途牛牛
What drives Veracyte Inc. stock pricePhenomenal investment performance - Autocar Professional
Is Veracyte Inc. a good long term investmentHigh-yield capital appreciation - jammulinksnews.com
Published on: 2025-07-22 20:34:08 - jammulinksnews.com
CSBR names Veracyte exec Robert Brainin CEO; 700K option package | DNN SEC FilingForm 6-K - Stock Titan
Are Veracyte, Inc.'s (NASDAQ:VCYT) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - simplywall.st
Principal Financial Group Inc. Raises Holdings in Veracyte, Inc. (NASDAQ:VCYT) - Defense World
Veracyte Inc Stock (VCYT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):